New paper titled “Microenvironment Influence of a Novel Bioengineered Wound Product, APIS®: A Preliminary In Vitro Analysis of Inflammatory Marker and Growth Factor Secretion” with our partners at SweetBio, Inc. was published this week. The preliminary in vitro evaluation suggests that the novel bioengineered wound product has the potential to instill balance to the wound microenvironment by…

iFyber scientists worked with Allergan Aesthetics on two articles in Aesthetic Surgery Journal evaluating antimicrobial solutions used in breast implant soaking and breast pocket irrigation.  Part 1 looked at efficacy against planktonic bacteria, Part 2 at biofilm-associated bacteria. https://doi.org/10.1093/asj/sjaa309 https://doi.org/10.1093/asj/sjaa308  

We’d like to share the recent publication in Wound Management & Prevention by the great team at Rochal Industries Inc and iFyber team led by Nina Bionda. It highlights the efficacy of wound cleansers in two relevant biofilm models. The ex vivo porcine dermal model of mature biofilms is routinely used by our clients for the evaluation of…

iFyber announced that it has entered into multiple agreements with the Department of Defense (DoD), which will provide funds for the development of two distinct types of antimicrobial dressings designed for different use scenarios. Read the press release here.